The Best of the USCAP Journals
WEDNESDAY, MARCH 27, 2024 8:00 – 9:00 AM
Baltimore Convention Center – Room 307
Join the editors-in-chief of the USCAP journals for a fast-paced review of 10 of the best papers published in 2023. Dr. George J. Netto (Modern Pathology) and Dr. David M. Berman (Laboratory Investigation) have each chosen 5 papers that cover a variety of subspecialties and highlight some of the newest techniques and latest advances in pathology. Short question and answer sessions will follow each presentation. A selection of senior journal editors and authors will be available for further discussion with attendees.
Through guided review of papers published in USCAP journals, participants will learn to:
- Use observational gene and protein expression data to confirm the clinical relevance of experimental findings
- Create compelling arguments for research impact
- Visually communicate complex scientific concepts
David M Berman, MD, PhD
Editor-in-Chief, Laboratory Investigation
Dr. Berman is Professor and Head of the Department of Pathology and Molecular Medicine at Queen’s University and the Editor-in-Chief of Laboratory Investigation. He practices urologic surgical pathology at Kingston Health Sciences Centre in Kingston, Ontario, Canada. His research laboratory focuses on basic, translational, and clinical aspects of prostate and bladder cancer. This research helped establish embryonic signaling pathways as important drivers of cancer progression and as therapeutic targets, identified bladder cancer stem cells and has helped improve surgical pathology practice.
George J. Netto, MD
Perelman School of Medicine at the University of Pennsylvania
Editor-in-Chief, Modern Pathology
George J. Netto, MD received his medical degree from Damascus University before residency in anatomic and clinical pathology at Baylor University Medical Center and fellowships in surgical pathology at the Washington University School of Medicine, and in urologic pathology at Memorial Sloan-Kettering Cancer Center. In 2005 he joined the Johns Hopkins School of Medicine faculty and served as Director of Surgical Pathology Molecular Diagnostics and Professor of Pathology, Urology, and Oncology. He moved on to become the Pathologist-in-Chief and Senior Scientist at the O’Neal Comprehensive Cancer Center and the Civitan International Research Center at the University of Alabama at Birmingham. He currently serves as the Simon Flexner Professor and Chair for the Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania.
His research, focused on urologic and molecular diagnostic pathology, has helped characterize the incidence and role of TMPRSS2-ERG fusion and PTEN loss as a prognostic biomarker in prostate adenocarcinoma. Dr. Netto and collaborators are credited with the important discovery related to the high incidence of TERT gene promoter mutation in muscle-invasive bladder cancer and upper tract urothelial carcinoma. The discovery led to the development of a novel, non-invasive urine- based genetic assay for the early detection of bladder cancer, UroSEEK, that promises a significant decrease in the need for repeated invasive and costly cystoscopy procedures.
Dr. Netto is editor in chief for Modern Pathology. He serves on the editorial boards of the journals of Human Pathology, Pathology, and Virchow Archives European Journal of Pathology and serves as an expert member of the World Health Organization (WHO) Blue Book Editorial Board for the upcoming Urinary and Male Genital Tumours volume. He served previously as an associate editor for translation and basic science for the journal Urology and currently serves as an associate editor for Advances in Anatomic and Molecular Pathology. He has authored or co-authored more than 375 articles and chapters, including four books in urologic pathology, and is the editor of a widely recognized text ook on genomics in pathology, Genomic Applications in Pathology, currently in its second edition.